On a Dubai clinic menu, PRP sounds almost too elegant to argue with: a little of your own blood, spun and reinjected, no scalpel, no downtime, a quiet promise of regrowth at the bottom of the price list. The pattern you see once you compare a few of these pages is that they all lead with the promise and skip the one line that decides whether it works for you. PRP works on follicles that are still alive but weakened. It cannot revive follicles that are already dead or gone. Hold that, and the whole confusing field of non-surgical hair loss treatment in Dubai falls into order. Thinning where the hair has gone fine and sparse but not bald is the territory where PRP and the medical options earn their place. A scalp that is genuinely bald, with no follicle left to wake up, is surgical territory, and no injection changes that arithmetic.
That is a less flattering pitch than the one most clinic pages run, and it is the more useful one. PRP, platelet-rich plasma, is the lead non-surgical treatment offered across Dubai, and the honest version of its story tells you more than the marketing does. The evidence is real but mixed. The mechanism is plausible and supported in the lab. Around a third to half of patients see a benefit, some only a slowing of shedding rather than visible regrowth. It works best alongside the proven medicines, not instead of them, and it is no substitute for a transplant. This guide walks the whole non-surgical field by how strong the evidence actually is, sets out realistic AED pricing for 2026, and maps who is a candidate and who is quietly being sold the wrong treatment.
What PRP is, and how it actually works
The procedure itself is simple and the biology behind it is well understood, even where its clinical payoff is debated. Blood is drawn from your arm, much as for a routine blood test, then spun in a centrifuge that separates it by weight. The spin concentrates the platelets, typically to around five times their normal level, into a small fraction of plasma. That platelet-rich plasma is then injected into the thinning areas of the scalp, placed to reach the base of the follicle where the dermal papilla sits, the cluster of cells that governs each hair's growth cycle. Harvard Health gives a clear lay account of the same sequence.
Platelets are not just for clotting. When activated they release a cascade of growth factors, and several of those have a plausible role in hair biology. PDGF and FGF stimulate the dermal papilla cells to proliferate. VEGF drives the growth of new small blood vessels, raising the capillary supply around each follicle. IGF-1 extends anagen, the active growth phase, and delays the follicle's slide into rest. EGF is associated with thicker shafts, and TGF-beta moderates inflammation. The chronic, low-grade inflammation around follicles is itself implicated in androgenetic alopecia, the common pattern loss, so an anti-inflammatory action is part of the rationale too. The mechanism work behind these claims is set out in the peer-reviewed literature on PMC.
PRP is injected directly into the thinning zones, placed to reach the base of each follicle where the growth cycle is governed.
Two honest caveats belong here, because they shape what PRP can and cannot promise. The first is that the precise biological mechanism remains, in the words of both the International Society of Hair Restoration Surgery and Harvard, not fully understood. The second is a genuine wrinkle: not every platelet factor is pro-hair. Platelet Factor 4, a chemokine that platelets release, has been shown in laboratory work to inhibit follicle growth and raise androgen-receptor expression. It is a single mechanistic finding rather than a clinical verdict, but it is a fair reminder that concentrating platelets is not a simple case of more is better. On that point, higher platelet concentrations do not scale up the benefit in a straight line. A threshold appears to be enough, beyond which extra concentration adds little.
The honest evidence: a real signal, low certainty
This is the section most pages skip, and it is the one that should anchor any decision. The headline number, repeated fairly consistently across the better studies, is a density gain of roughly 25 to 28 hairs per square centimetre versus control in androgenetic alopecia. A 2024 systematic review and meta-analysis put it at 27.55 additional hairs per square centimetre, with a confidence interval of 14.04 to 41.06, and that figure is echoed by other pooled analyses landing around 25 to 26. As a direction of travel, the signal is real and it points the right way.
The caveats sit right next to that number and matter just as much. The same 2024 review graded the underlying evidence as low quality. Heterogeneity between studies was extreme, with statistical inconsistency in the range that usually means the trials are barely measuring the same thing. Sample sizes were small, follow-up was short, and the analysis detected publication bias, the tendency for positive results to reach print while null ones do not. You can read the full systematic review on PMC. The practical upshot is that PRP should never be described as something that definitively regrows hair. The fair description is a treatment with a positive but uncertain density effect.
Two further findings sharpen the picture. The benefit shows up in hair count, not clearly in hair thickness. The same review found the effect on shaft diameter was small and not statistically significant, so claims that PRP makes individual hairs thicker are not well supported. And PRP does not beat the proven topical medicine. A 2025 meta-analysis of nine randomised trials found no significant difference in density between PRP and topical minoxidil. Patient satisfaction and hair-pull tests leaned towards PRP, but on the key clinical measure the authors concluded PRP shows no clear advantage over minoxidil. The cleanest professional summary comes from the ISHRS: PRP suits thinning rather than complete baldness, at least 30 to 50 per cent of patients see some benefit, some of that being reduced shedding rather than regrowth, it is off-label, it is not guaranteed, and it cannot match the result of a transplant.
The non-surgical field, ranked by evidence
PRP is one option among several, and the useful way to compare them is by how much evidence stands behind each, not by how new or premium they sound. Ranked honestly, the proven medicines sit at the top, PRP sits in the legitimate middle as an adjunct, and the most heavily marketed regenerative treatments sit at the bottom on emerging evidence.
THE NON-SURGICAL FIELD
Minoxidil and finasteride
Proven first line
- Evidence
- Strong, FDA-approved
- Role
- Medical baseline; combine with PRP
- Note
- Finasteride not for women of childbearing potential
PRP
Evidence-based adjunct
- Evidence
- Moderate; density gain real, thickness unproven
- Role
- Slow loss, densify early-to-moderate thinning
- Note
- Autologous; needs maintenance
Low-level laser (LLLT)
Modest, FDA-cleared
- Evidence
- Modest; real-world response 23-30%
- Role
- Safe adjunct, home or clinic
- Note
- Not cleared for darker skin types
Mesotherapy
Limited evidence
- Evidence
- Weak; small studies
- Role
- Adjunct, vitamin and peptide cocktails
- Note
- Few comparative trials
Exosomes and polynucleotides
2025-26 trend
- Evidence
- Emerging; exosomes not FDA-approved
- Role
- Premium regenerative upgrade
- Note
- Regulatory caution; marketing ahead of data
The proven baseline is minoxidil and finasteride, and any serious conversation about hair loss starts there. Topical minoxidil, applied daily, adds roughly 18 non-vellus hairs per square centimetre over 48 weeks in the trial data, though about 60 per cent of users respond poorly because of low activity of the scalp enzyme that converts minoxidil to its active form. Low-dose oral minoxidil, the major prescribing trend of the last two years, is effective but off-label, with dose-dependent unwanted hair growth and cardiac effects that are uncommon at low doses. The 2025 minoxidil review on Frontiers covers both routes. Finasteride, a 5-alpha-reductase inhibitor that lowers scalp DHT, is the FDA-approved first line for men.
Below the medicines, PRP holds a legitimate middle place as an adjunct, its standardisation problem the main thing holding it back from a stronger grade. Low-level laser therapy, or photobiomodulation, has been FDA-cleared since 2007 and carries essentially no side effects, but its real-world response rate is modest at around 23 to 30 per cent, and the devices are not cleared for the darker skin types common across the UAE. Mesotherapy, injected vitamin and peptide cocktails, rests on weak evidence with few comparative trials.
Low-level laser therapy is FDA-cleared and side-effect free, but its real-world response rate is modest and the devices are not cleared for darker skin types.
At the bottom sit the two treatments Dubai clinics push hardest in 2026: exosomes, cell-derived vesicles, and polynucleotides, fragments of salmon or trout DNA. Both are premium, non-hormonal and marketed as the advanced upgrade over PRP. The evidence does not yet justify that positioning. Exosomes in particular are not FDA-approved and carry regulatory safety warnings, and unlike PRP they are typically lab-derived rather than taken from your own blood. A comparative review on PMC sets out where each of these regenerative options actually stands. The plain reading is that newer and pricier is not the same as better supported.
The medical baseline, and why combinations win
The single most consistent finding across the literature is that combinations beat any one treatment alone, which is why the better Dubai clinics treat PRP as part of a plan rather than a standalone fix. Topical minoxidil 5 per cent paired with finasteride 0.25 per cent outperforms either on its own. A network analysis of minoxidil combinations ranked PRP added to minoxidil among the strongest performers. One 2024 study found PRP plus finasteride beat minoxidil plus finasteride by around 16.8 per cent on density at six months, though that is a single study and should be read as suggestive rather than settled.
Finasteride deserves an honest paragraph of its own, because its risks are genuinely debated. Post-finasteride syndrome, a cluster of sexual, mood and cognitive symptoms reported to persist after stopping the drug, remains unresolved on causality. The fair framing is a contested risk rather than a settled fact, and it is worth a frank conversation with a prescribing doctor rather than a dismissal in either direction. Finasteride is also teratogenic and is contraindicated in women of childbearing potential, meaning it should not be used by women who could become pregnant. For those women, minoxidil, with or without spironolactone, is the usual route. A 2025 randomised trial found topical finasteride 1 per cent as safe and effective as minoxidil 5 per cent in female-pattern hair loss, which widens the options, but the prescribing caution stands.
PRP for women
Female hair loss follows a different pattern from the male one, and PRP fits a defined slice of it. Where men recede and go bald in zones, women typically thin diffusely across the central scalp, the part and the crown, while the frontal hairline is usually preserved. The scale used is Ludwig, graded one to three. PRP is a reasonable candidate treatment at Ludwig I to II, the mild-to-moderate stages where follicles are present but miniaturising, and the studies in female-pattern loss report density improvements of around 30 per cent at early stages, at low-to-moderate certainty. As with men, starting early matters, because PRP supports follicles that are still there rather than rebuilding ones that have gone.
The catch specific to women is that female loss often reaches the sides and back too, the very zone a transplant would draw from, which is one reason surgery suits fewer women than men. That makes the non-surgical and medical options proportionally more important for women, and it makes an in-person diagnosis, rather than a self-assessment from a photo, more important still. Diffuse thinning has several causes beyond pattern loss, and the treatment that helps depends on which one is at work.
The protocol, and a realistic timeline
PRP is not a single appointment, and the schedule is where expectations should be set honestly. The standard course is three induction sessions spaced about a month apart, followed by maintenance every four to six months to hold the result. Skipping induction in favour of a single session is unlikely to do much.
WHAT TO EXPECT
Induction
3 monthly sessions
- Each visit
- 45-90 minutes; injection 10-20
- Steps
- Consult, blood draw, centrifuge, inject
First signs
2-4 weeks
- What changes
- Reduced shedding first
Visible density
3-6 months
- Peak
- Around 6-12 months
Maintenance
Every 4-6 months
- Durability
- Roughly 12-18 months without top-ups
A single visit runs roughly 45 to 90 minutes, of which the injections take only 10 to 20. The sequence is a consultation and diagnosis, which a clinic that skips it is doing wrong, then a blood draw of around 30 to 60 ml, about ten minutes in the centrifuge, scalp preparation with a topical numbing cream, and fine-needle injections into the thinning zones. As for results, the first change is usually less shedding within two to four weeks. Visible density follows at three to six months, peaks somewhere around six to twelve months, and lasts roughly 12 to 18 months without top-ups. That durability figure is drawn more from clinical practice than from long-term trial data, which is itself a noted gap, so treat it as a working expectation rather than a guarantee.
Aftercare is straightforward and short. Leave the hair unwashed for around 24 hours, skip topical products and colour for 48, and avoid heat, heavy sweat and exercise for about a day. Hold off on alcohol and smoking for roughly 24 hours, and in the week before a session avoid blood-thinning agents, including aspirin, ibuprofen and fish oil, for five to seven days, since they blunt the platelet effect. Side effects are mild and pass: tenderness, a little swelling, pinpoint bleeding, the occasional headache, and sometimes a temporary shed between two and six weeks that resolves on its own. Because the material is your own blood, the safety profile is strong. PRP is not for everyone, though. A low platelet count or platelet dysfunction, blood disorders, anticoagulant therapy, an active scalp infection, severe anaemia or uncontrolled diabetes all rule it out or require careful review.
What PRP costs in Dubai
PRP pricing in Dubai is commercial, unregulated and frequently advertised as a teaser per-session figure that understates the real outlay. The numbers below are indicative 2026 market estimates compiled from Dubai clinic pages, and most exclude the 5 per cent VAT that is often added on top.
INDICATIVE 2026 PRICING
In the mainstream of the market a single session runs roughly AED 700 to 1,500, with entry offers dipping below and premium clinics in Jumeirah, DIFC and Marina reaching above. A full three-session induction course runs around AED 1,500 to 4,000, and ongoing maintenance, two to three sessions a year, comes to roughly AED 3,000 to 6,000 annually. Several things move the price: whether a doctor or a technician performs the injection, the quality of the kit and the resulting platelet concentration, the location and prestige of the clinic, and any bundled add-ons. One number is worth treating as a warning sign. PRP advertised below AED 500 a session is a red flag for low platelet concentration, a non-physician injector, or both. Cheap PRP is often weak PRP.
Set against the wider field, PRP sits in the middle on price as well as evidence. Mesotherapy is cheaper per session, the premium regenerative treatments markedly dearer, and the comparison is worth seeing side by side before a clinic steers you towards the costliest option.
PER-SESSION COST
The medical baseline is cheaper still and recurs as a smaller monthly cost. Topical minoxidil runs roughly AED 40 to 120 a month, oral finasteride around AED 200 to 500, and a low-level laser cap is a one-off device purchase from about AED 4,200. It is worth holding the cost of PRP against surgery too, because the comparison reframes it. A hair transplant in Dubai is a one-off outlay, FUE running roughly AED 10,000 to 25,000 and DHI 15,000 to 30,000, which is somewhere between five and fifteen times a single PRP course. The difference is that a transplant is paid once and PRP recurs indefinitely. For the full surgical picture, our complete hair transplant cost guide for Dubai breaks down the techniques and the totals. The honest way to weigh the two is not which is cheaper per appointment, but which actually fits the loss you have.
Who suits non-surgical care, and who needs surgery
Return to the opening line, because it is the whole framework. PRP and the medical options work on follicles that are alive but weakened. A transplant is the only thing that addresses follicles that are dead or gone. Mapping that onto the staging scales sorts most readers cleanly.
ARE YOU A CANDIDATE
Non-surgical (PRP and medical)
Live but weakened follicles
- Best for
- Early-to-moderate thinning, diffuse loss
- Stage
- Norwood II-III, Ludwig I-II
- Also
- Slowing active loss, maintaining a transplant
Transplant (surgery)
Dead or absent follicles
- Best for
- Established baldness, bald hairline
- Stage
- Norwood III and beyond, Ludwig III
- Also
- Scarred areas where follicles are gone
Non-surgical care suits early-to-moderate thinning, diffuse loss across the crown and mid-scalp, anyone wanting to slow active shedding, female-pattern thinning at Ludwig I to II, those not ready for surgery, and anyone maintaining a transplant. In Norwood terms, a stage I to II is for monitoring or medical treatment, a II to III with early diffuse thinning is genuine PRP territory, and a III with bald scalp is where surgery enters. Surgery is the answer for established baldness at the advanced Norwood stages, a receded hairline with no follicles left, and scarred areas where the follicles have gone. The honest line that disappoints some readers is the most important one: where the scalp is truly bald, PRP has nothing to act on. There is no follicle to stimulate, and a course of injections is money spent on a treatment that cannot work.
There is also a real and underdiscussed role for PRP alongside surgery rather than against it. Used around a transplant, PRP appears to improve graft survival, with studies reporting figures roughly 11 to 13 per cent higher at three and six months, some reporting around 15 per cent higher follicular density, plus faster healing and reduced post-operative shedding. It also helps maintain the native, non-transplanted hair around the grafts, which can otherwise keep thinning and leave the new hair looking stranded. The systematic-review authors are careful to call this promising rather than proven, so it belongs in the plan as an adjunct benefit, not a guarantee. If you are weighing surgery, our guide to choosing a hair transplant clinic in Dubai covers how to assess a surgeon properly, and you can compare DHA-licensed hair restoration clinics in our directory when you are ready to book an in-person assessment.
Choosing safely: the DHA check that protects you
The strongest consumer protection in Dubai is also the simplest, and it costs nothing. PRP and every other injectable must be performed in a licensed facility, under the Dubai Health Authority within Dubai, by an individually licensed practitioner. You can verify both the clinic and the doctor yourself before booking, through the public DHA Sheryan and Dubai medical directory lookup, which shows licence type, status and expiry. If a practitioner's status is anything other than active, do not proceed. Every injectable product and device used should also be registered with the federal health authority.
The DHA prohibits exaggerated claims and guaranteed-result promises, which gives you a clean test for the marketing you encounter. Treat any clinic promising guaranteed regrowth with scepticism, because no honest provider can promise it and the regulator does not permit the claim. Be equally wary of suspiciously cheap PRP, which usually means a weak preparation or a non-physician injector. A clinic that publishes balanced material on the options, such as Hortman Clinics, which sets out the PRP-versus-exosome comparison candidly, is showing the kind of honesty worth looking for. The consultation itself is part of the safety check. A proper diagnosis of why you are losing hair should come before any needle, and a clinic that moves straight to selling a course without one has told you something useful about how it operates.
Common questions
Does PRP really work for hair loss?
For early-to-moderate thinning where the follicles are still alive, yes, it can slow shedding and modestly improve density. The evidence points in a positive direction but is mixed and of low-to-moderate certainty. It works best combined with minoxidil or finasteride, and it will not regrow areas that are already bald.
How much is PRP hair treatment in Dubai?
Roughly AED 700 to 1,500 a session in the mainstream of the market, with entry offers lower and premium clinics higher. A typical three-session course runs about AED 1,500 to 4,000, before the 5 per cent VAT many clinics add on top. PRP advertised below AED 500 a session is a red flag.
How many PRP sessions do I need?
Usually three monthly induction sessions, then maintenance every four to six months to hold the result.
Is PRP better than a hair transplant?
They solve different problems, so the comparison is the wrong one. PRP maintains and improves existing thinning hair. A transplant is the only option that permanently restores genuinely bald areas. They are complementary, not ranked against each other.
Does PRP work for women?
Yes, particularly female-pattern thinning at Ludwig I to II, with around 30 per cent density improvement reported at early stages at low-to-moderate certainty. Starting early helps, and an in-person diagnosis matters because diffuse thinning has several causes.
Is PRP permanent?
No. It is supportive and needs ongoing maintenance. Results typically last around 12 to 18 months without top-ups.
Can PRP regrow a receding hairline?
Only if the follicles there are still alive but weakened. A hairline that is truly bald, with no follicles left, needs a transplant.
PRP versus exosomes?
Exosomes show promising early results and skip the blood draw, but the evidence is newer and less mature, and their regulatory status carries cautions, since exosomes are not FDA-approved. PRP has more and higher-tier evidence today and uses your own blood.
Can I combine PRP with minoxidil or finasteride?
Yes, and most dermatologists recommend it. The combination consistently outperforms PRP on its own.
What should I avoid after PRP?
No hair washing for around 24 hours, no heat, sweat or exercise for about a day, no alcohol or smoking for roughly 24 hours, and no harsh products or hair colour for 48 hours. Do not scratch the scalp while it settles.
Sources and methodology
The medical and efficacy claims here are drawn from peer-reviewed systematic reviews and meta-analyses on PubMed and PMC, alongside professional and academic sources including the ISHRS, Harvard Health, Mayo Clinic and Cleveland Clinic, dated 2024 to 2025 where possible. The evidence for PRP in androgenetic alopecia is genuinely mixed: positive in direction on density, low-to-moderate in certainty, with no standardised protocol and an unproven effect on shaft thickness. All AED figures are indicative 2026 market estimates compiled from Dubai clinic price pages and aesthetic directories. They vary by clinic, exclude the 5 per cent VAT most clinics add, and should be confirmed directly. This article is informational only and not individual medical advice. Confirm your suitability, and verify the clinic and practitioner licence on the DHA portal, before any treatment. Reviewed 25 June 2026 by the Bellora Team.
- PMC, 2024 systematic review and meta-analysis, PRP density effect and low-quality grade: PMC11551241
- PMC, PRP mechanism, growth factors and the standardisation problem: PMC12071426
- International Society of Hair Restoration Surgery, PRP patient reference, 30 to 50 per cent benefit, off-label: ishrs.org
- Harvard Health, PRP mechanism and honest caveats: health.harvard.edu
- PMC, comparative review of PRP, photobiomodulation, stem cells and exosomes, with regulatory caution: PMC12821594
- Frontiers, 2025 minoxidil review, topical and low-dose oral: fphar.2025.1718208
- Dubai Health Authority, Sheryan licence and medical directory lookup: services.dha.gov.ae
- Indicative AED pricing cross-referenced to UAE clinic and aggregator data dated 2025 to 2026; promotional floor prices excluded as loss-leaders.